Sub Menu

Management Team

Board of Directors

Sci. Advisory Board

A new vision for anitplatelet therapy

8036 El Rio

Houston, Tx 77056

713.491.4449 - Main

713.748.3387 - Fax

 

main

Management Team

President/CEO
Edward R. Teitel
MD, JD, MBA
  • Former Sr. VP.Chief Medical Officer-public medical device company
  • Vascular surgeon, business, legal experience and expertise
  • Antiplatelet/anitcoagulant subject matter expert
Chief Financial Officer
Clarice Motter
CPA
  • Over 20 years experience in both private and public sectors
  • Experience in all phases of companies, including startup, pre-IPO, IPO, and M & A
Chief Technical Officer
Sivaprasad “SP” Sukavaneshvar
PhD
  • Entrepreneur and well-known research scientist on blood, platelets and medical device hemocompatibility
  • ThromboVision co-founder and Board of Directors member
VP, Sales and Marketing
Alan Jernigan
MBA
  • 20 years experience in in-vitro diagnostics sales and marketing, including the Abbott I-Stat program
  • Experienced in building sales teams for early stage medical companies
Director, Engineering
Wenjeng Li
MSME, MBA
  • Extensive engineering, project management, and point-of-care device experience
  • Project manager of ThromboVision disposable cassette development and design
  • Multiple patents
Regulatory & Clincal Affairs
Consultants
 
  • Greenleaf - Andrew von Eschenbach, MD & Patrick Ronan: Former FDA Commissioner & Chief of Staff
  • MDCI - Cynthia Sinclair
  • Promedt, GmbH - Consultant for European regulatory affairs
  • Don Martin- Regulatory, QA/QC
Director, Manufacturing
Craig Hebel
 
  • Over 17 years of experience in GMP manufacturing
  • Extensive background in Biopharmaceuticals, Gene Therapy and Sterile Products
  • EMEA audit experience